 |
|
OUR PEOPLE
Alexander Sobolev
Patent Attorney • Moscow
SEARCH OUR PEOPLE
|
|
Alexander Sobolev
|
|
|
Alexander Sobolev is a registered patent attorney in Gowlings' Moscow office.
Alexander has extensive experience in patent drafting and prosecution in the fields of pharma, biotech, medicine and organic chemistry before the Russian and Eurasian Patent Offices and in the former Soviet Republics. He has been involved in the preparation of patentability and freedom-to-operate opinions for a global leading generic drug manufacturer. Furthermore, he has acted as a counsel in the proceedings before the Chamber for Patent Disputes.
Prior to joining Gowlings, Sobolev worked as a senior specialist with one of the leading IP rights protection firms in Russia.
Over his 25-year career, Sobolev has invented/authored several of his own patents. He has written extensively in the life sciences field in both Russian and English languages. Papers on IP Matters
- Sobolev A. Yu., Zalesov A. V. The use of the doctrine of equivalents while
construing the scope of protection of the inventions in the field of life
sciences in the courts. Invention (Izobretatel’stvo) 2004, IV(9), 9-24 (In
Russian).
- Agureev A.P., and Sobolev A.Yu. The objects with the intended use in medicine: the protection should be improved. Patents and Licences (Patenty i Litsensii) 2007, 7, 21-28 (In Russian).
- Sobolev A. Yu. The prolongation of the period of the action of exceptional rights and patent for the invention which relates to the medicinal product, to pesticide or to agrochemicals, who is guilty and what to do? Invention (Izobretatel’stvo) 2009, IX(7), 7-18 and IX(8), 27-40 (In Russian).
Research papers
Alexander had written more than 20 papers and more than 20 abstracts in national and international
peer-reviewed scientific journals. Below are selected papers published in the journals with
the highest impact factor:
- Ismailov A. D., Sobolev A. Yu., and Danilov V. S. Bioluminescence decay
kinetics in the reaction of bacterial luciferase with different aldehydes.
J. Biolumin. Chemilumin. (1990), 5, 213-217.
- Qian W., Zhu S., Sobolev A. Y., and Wek R. C. Expression of Vaccinia virus
K3L protein in yeast inhibits eukaryotic initiation factor-2 kinase GCN2 and
the general amino acid control pathway. J. Biol. Chem. (1996), 271, 13202-
13207.
- Zhu S., Sobolev A. Y., and Wek R. C. Histidyl-tRNA synthetase-related
sequences in GCN2 protein kinase regulate in vitro phosphorylation of eIF-2.
J. Biol. Chem. (1996), 271, 24989-24994.
- Mikhailovich V., Lapa S., Gryadunov D., Sobolev A., et al. Identification of
rifampin-resistant Mycobacterium tuberculosis strains by hybridization, PCR,
and ligase detection reaction on oligonucleotide microchips.
J. Clin. Microbiol. (2001), 39, 2531-2540.
- Lapa S., Mikheev M., Shchelkunov S., Mikhailovich V., Sobolev A., et al.
Species-level identification of orthopoxviruses with an oligonucleotide
microchip. J. Clin. Microbiol. (2002), 40, 753-757.
- Yurchenko J., Budilov A., Deyev S., Khromov I., and Sobolev A. Cloning of
an alkaline phosphatase gene from the moderately thermophilic bacterium Meiothermus ruber and characterization of the recombinant enzyme.
Mol. Genet. Genom. (2003), 270, 87-93.
- Bobryshev Y. V., Golovanova N. K., Tran D., Samovilova N. N., Gracheva
E. V., Efremov E. E., Sobolev A. Y., et al. Expression of GM3 synthase in
human atherosclerotic lesions. Atherosclerosis (2006), 184, 63-71.
Patents:
- Inventorship in 4 RU patents, 1 EA patent and 1 KZ patent.
|
|
|
|
|
|
|
